Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from Pharmacorp Rx Inc. ( (TSE:PCRX) ).
PharmaCorp Rx Inc. announced the approval from the TSX Venture Exchange for the supplemental listing of 27,427,500 common share purchase warrants, which will be available for trading starting November 17, 2025. This move is part of the company’s strategy to enhance its financial operations and expand its market presence, potentially impacting its growth and acquisition capabilities in the pharmacy sector.
More about Pharmacorp Rx Inc.
PharmaCorp Rx Inc. is a Canadian pharmacy acquisition and ownership platform that focuses on empowering pharmacists as equity partners and supporting succession for retiring pharmacy owners. The company is building a national network of community pharmacies under the PharmaChoice Canada banner and currently operates seven such pharmacies. PharmaCorp aims to acquire both PharmaChoice Canada bannered and independent pharmacies across Canada, rebranding non-bannered locations under the PharmaChoice Canada platform.
Average Trading Volume: 77,617
Technical Sentiment Signal: Sell
Current Market Cap: C$49.48M
Find detailed analytics on PCRX stock on TipRanks’ Stock Analysis page.